United States · Bill · HR
H.R. 2937 (111th)
MRSA Infection Prevention and Patient Protection Act
Introduced
18 June 2009
Last action
19 June 2009 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Speier, Jackie [D-CA-14], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Capps, Lois [D-CA-24], Rep. Eshoo, Anna G. [D-CA-18], Rep. Lee, Barbara [D-CA-12], Rep. Moran, James P. [D-VA-8], Rep. Wittman, Robert J. [R-VA-1], Rep. Rothman, Steven R. [D-NJ-9], Rep. Kilroy, Mary Jo [D-OH-15], Rep. Sestak, Joe [D-PA-7], Rep. Kildee, Dale E. [D-MI-5]
Subjects
Healthcare
Source updated
28 November 2025
Summary
MRSA Infection Prevention and Patient Protection Act - Directs the Secretary of Health and Human Services (HHS) to promulgate regulations relating to MRSA (methicillin-resistant Staphylococcus aureus), including regulations that provide a list of best practices for preventing MRSA infections and such other antibiotic resistant pathogens as the Secretary determines appropriate. Requires each acute care hospital to screen each patient entering an intensive care unit or other high-risk hospital department. Directs the Secretary to: (1) establish a process and a timetable for extending the screening requirements to patients admitted to all hospitals by January 1, 2014; and (2) report to Congress on whether payment adjustments should be made under Medicare to assist certain hospitals in defraying the cost of screening for, and the subsequent treatment of, MRSA or other infections. Requires all hospitals to: (1) comply with specified MRSA best practices, including contact precautions and patient notification; and (2) report hospital-acquired MRSA and other infections that occur in the facility. Requires the Secretary to: (1) establish systems for identifying infected transferred patients and for promptly informing any facility that has transferred an infected patient; and (2) publish the names of providers who fail to take steps to reduce the incidence of MRSA infections. Permits a hospital to apply to the Secretary for a one-year increase in the amount of the capital-related costs payment made to the hospital under the prospective payment system to provide for the rapid implementation of MRSA screening programs and initiatives. Requires the Director of the Centers for Disease Control and Prevention (CDC) to award a grant for a pilot program to develop a rapid, cost-effective method for testing for MRSA using a molecular testing method. .
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
18 June 2009
Introduced
Referred to House Energy and Commerce
Source: IntroReferral
18 June 2009
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
18 June 2009
Introduced
Introduced in House
Source: IntroReferral
18 June 2009
Introduced
Introduced in House
Source: IntroReferral
19 June 2009
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 18 June 2009 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 18 June 2009
Introduced in House (PDF)
Introduced in House · EN · 18 June 2009
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 18 June 2009
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Speier, Jackie [D-CA-14] · D · Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Rep. Capps, Lois [D-CA-24] · D · Sponsor
- Rep. Eshoo, Anna G. [D-CA-18] · D · Sponsor
- Rep. Lee, Barbara [D-CA-12] · D · Cosponsor
- Rep. Moran, James P. [D-VA-8] · D · Cosponsor
- Rep. Wittman, Robert J. [R-VA-1] · R · Cosponsor
- Rep. Rothman, Steven R. [D-NJ-9] · D · Cosponsor
- Rep. Kilroy, Mary Jo [D-OH-15] · D · Cosponsor
- Rep. Sestak, Joe [D-PA-7] · D · Cosponsor
- Rep. Kildee, Dale E. [D-MI-5] · D · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
Related records
- related to ← MRSA Infection Prevention and Patient Protection Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/111th-congress/house-bill/2937
- Open data entity: https://api.congress.gov/v3/bill/111/hr/2937
- us · 111-hr-2937 · source updated 28 November 2025